Opna Bio

MyCural Therapeutics

This company develops small molecule drugs targeting the MYC oncoprotein to treat patients with aggressive, high-risk cancers.

Accent Therapeutics

This biopharmaceutical company develops small molecule precision therapies for patients with various types of cancer.

OnCusp Therapeutics

This biopharmaceutical company develops oncology therapies by advancing preclinical drug candidates through clinical trials for cancer patients and potential pharmaceutical partners.

Oncopeptides AB

This biotech company develops targeted therapies for patients with difficult-to-treat hematological diseases, specifically focusing on multiple myeloma treatments.

Kartos Therapeutics

This biopharmaceutical company develops oral small-molecule therapeutics to treat blood cancers and solid tumors for patients with unmet clinical needs.

D3 Bio

This biotechnology company develops precision medicines and oncology therapeutics for patients with cancer and immunological conditions.

Imago BioSciences

This biopharmaceutical company develops small molecule inhibitors to treat patients with myeloproliferative neoplasms and other bone marrow diseases.

Kronos Bio

This biopharmaceutical company develops small molecule therapeutics targeting transcription factors for patients with cancer and autoimmune diseases.